{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-115263","form_type":"8-K","ticker":"ASTH","cik":"0001083446","company_name":"Astrana Health, Inc.","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.159250+00:00","generated_at":"2026-06-08T13:20:28.569651+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"ApolloMed Q3 revenue $348.2M (+10% YoY), EPS $0.47; acquires CFC for ~$202M","bullets":["Total revenue $348.2M (+10% YoY); net income $22.1M ($0.47 diluted EPS) vs $23.2M ($0.50).","Adjusted EBITDA $52.0M (15% margin) vs $57.1M; full-year guidance narrowed to $1.34-1.39B revenue.","Agreed to acquire Community Family Care (200k+ members) for ~$202M cash/equity; expected close Q1 2024.","Entered $300M term loan amendment to expand credit facility to $700M; $100M stock repurchase from APC.","Partnerships: Associated Hispanic Physicians (~25k members), Advantage Health Network, Wider Circle CalAIM."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-115263","json":"https://secwatch.observer/filing/0001104659-23-115263.json","markdown":"https://secwatch.observer/filing/0001104659-23-115263.md","text":"https://secwatch.observer/filing/0001104659-23-115263.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923115263/0001104659-23-115263-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923115263/tm2330057d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T13:20:28.569651+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6d108d5eabc0f85bf92aa5a41b4e3ef5ded75fa4","claim":"Astrana Health, Inc. reported third quarter ended September 30, 2023 results: revenue $348.2 million, net income $22.1 million, EPS $0.47.","evidence_excerpt":"ahead.” Financial Highlights for Third Quarter Ended September 30, 2023: All comparisons are to the quarter ended September 30, 2022 unless otherwise stated. · Total revenue of $348.2 million, up 10% from $317.0 million · Care Partners revenue of $326.5 million, up 11% from $293.6 million · Net income attributable to ApolloMed of $22.1 million, compared to $23.2","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923115263/0001104659-23-115263-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Revenue","value":"$348.2 million"},{"label":"Net income","value":"$22.1 million"},{"label":"EPS","value":"$0.47"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}